▶ 調査レポート

アブレーション技術の世界市場:技術別(高周波、レーザー・光、超音波、電気、凍結療法、マイクロ波、水熱)、地域別分析

• 英文タイトル:Global Ablation Technologies Market - Segmented by Technology and Geography - Growth, Trends, and Forecast (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。アブレーション技術の世界市場:技術別(高周波、レーザー・光、超音波、電気、凍結療法、マイクロ波、水熱)、地域別分析 / Global Ablation Technologies Market - Segmented by Technology and Geography - Growth, Trends, and Forecast (2018 - 2023) / B-MOR-08008資料のイメージです。• レポートコード:B-MOR-08008
• 出版社/出版日:Mordor Intelligence / 2018年5月1日
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:Healthcare
• 販売価格(消費税別)
  Single User(1名様用)¥454,750 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥481,500 (USD4,500)▷ お問い合わせ
  Corporate User¥936,250 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、アブレーション技術の世界市場について調べ、アブレーション技術の世界規模、市場動向、市場環境、技術別(高周波、レーザー・光、超音波、電気、凍結療法、マイクロ波、水熱)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・アブレーション技術の世界市場インサイト
・アブレーション技術の世界市場環境
・アブレーション技術の世界市場動向
・アブレーション技術の世界市場規模
・アブレーション技術の世界市場規模:技術別(高周波、レーザー・光、超音波、電気、凍結療法、マイクロ波、水熱)
・アブレーション技術の世界市場:地域別市場規模・分析
・アブレーション技術の北米市場規模・予測
・アブレーション技術のアメリカ市場規模・予測
・アブレーション技術のヨーロッパ市場規模・予測
・アブレーション技術のアジア市場規模・予測
・アブレーション技術の日本市場規模・予測
・アブレーション技術の中国市場規模・予測
・アブレーション技術のインド市場規模・予測
・アブレーション技術の韓国市場規模・予測
・関連企業情報・競争状況

The ablation technologies market is expected to register a CAGR of 10.7%, during the forecast period. Rising incidence of cancer and prevalence of cardiovascular diseases are the major factors driving the growth of this market. In addition, increasing number of ablation procedures, hospitals, surgical, and ablation centers and emergence of next-generation ablation products and technologies are further aiding to the growth prospects of this market. However, the use of refurbished devices in developing countries and healthcare cost-containment measures taken in a number of developed countries can hinder the growth of this market.

Rising Incidence of Cancer

According to WHO, cancer is one of the leading causes of morbidity and mortality worldwide and approximately 14 million people suffered from cancer worldwide in 2012. Globally, every one in six deaths is due to cancer. The number of new cases is expected to rise by about 70% over the next two decades; globally, it accounted for 8.8 million deaths in 2015. Cancer accounts for 13% deaths worldwide. Early detection of cancer is gaining pace and ablation technology is highly effective in the surgery for minor cancers therefore it will fuel the growth of this market. This, along with other factors, like emergence of next-generation ablation products and technology and growing prevalence of cardiovascular diseases will act as a driver for the ablation technology market.

Used Only for Minor Surgeries

The major factor hindering the growth of tumor ablation market is that tumor ablation can only be used for minor surgeries, like small size of tumors. In general, for cancers of about 3 cm or less, which are accessible percutaneous, can be treated with tumor ablation completely. To completely remove a cancer by tumor ablation, it should be accessible and of appropriate size. Other cancers are difficult to kill using this method, therefore limiting its applications. The fact that the cancer is not detected early in most of the cases hinders the market growth of tumor ablation. Since, early detection of cancer is necessary to perform tumor ablation before the tumor grows more than 3 cm, limits the possibility of completely killing the cancer. This, along with healthcare cost-containment, measures and unfavorable regulatory scenario will act as a restraining factor for the growth of ablation technology market.

Ablation Technology Market to Grow Substantially in North America

The United States has the largest installed base of ablation systems in the world. The large installed base is mainly due to the high standards of healthcare infrastructure in the country, easy availability of sophisticated technology and increasing government funding on cancer research. The growing investments of many key players of this market have grown significantly. In addition, the focus on the development of products with innovative features and greater effectiveness has increased in recent times. Also, in Europe and APAC, will show promising growth in the forecasted years.

Key Developments in the Market

• October 2017 – Acutus Medical has announced that the US Food and Drug Administration (FDA) cleared the AcQMap high resolution imaging and mapping system as well as the AcQMap 3D imaging and mapping catheter this system will enable [practitioners] to rapidly map and re-map in order to visualise changes throughout the ablation procedure

Major players – ANGIODYNAMICS, INC. , ATRICURE, INC., BIOSENSE WEBSTER, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON INC.), BOSTON SCIENTIFIC CORPORATION, CONMED CORPORATION, GALIL MEDICAL INC. (ACQUIRED BY BTG INTERNATIONAL LTD.), MEDTRONIC PLC, OLYMPUS CORPORATION, SMITH & NEPHEW, AND ST. JUDE MEDICAL, INC., amongst others.

Reasons to Purchase this Report

• Current and future Ablation Technologies Market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Emergence of Next-generation Ablation Products and Technology
6.1.2 Rising Incidence of Cancer
6.1.3 Growing Prevalence of Cardiovascular Diseases
6.2 Market Restraints
6.2.1 Healthcare Cost-containment Measures
6.2.2 Used Only for Minor Surgeries
6.2.3 Unfavorable Regulatory Scenario
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Technology
7.1.1 Radiofrequency Ablators
7.1.1.1 Temperature-Controlled Radiofrequency Ablators
7.1.1.2 Fluid-Cooled Radiofrequency Ablators
7.1.2 Laser/Light Ablators
7.1.2.1 Excimer Laser Ablators
7.1.2.2 Cold Laser Ablators
7.1.3 Ultrasound Ablators
7.1.3.1 Ultrasonic Surgical Ablation Systems
7.1.3.2 High-Intensity Focused Ultrasound (HIFU) Ablators
7.1.3.3 Extracorporeal Shockwave Lithotripsy (ESWL) Systems
7.1.3.4 Magnetic Resonance-guided Focused Ultrasound (MRGFUS) Ablators
7.1.4 Electrical Ablators
7.1.4.1 Argon Plasma/Beam Coagulators
7.1.4.2 Irreversible Electroporation Ablators
7.1.5 Cryoablation Devices
7.1.5.1 Tissue Contact Probes
7.1.5.2 Tissue Spray Probes
7.1.5.3 Epidermal and Subcutaneous Cryoablation Devices
7.1.6 Microwave Ablators
7.1.6.1 Microwave Thermotherapy Devices
7.1.7 Hydrothermal Ablators
7.1.7.1 Endometrial Hydrothermal Balloon Ablation Devices
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia & New Zealand
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of the Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Angiodynamics, Inc.
9.2 Atricure, Inc.
9.3 Biosense Webster, Inc. (A Subsidiary of Johnson & Johnson Inc.)
9.4 Boston Scientific Corporation
9.5 Conmed Corporation
9.6 Galil Medical Inc. (Acquired By BTG International Ltd.)
9.7 Medtronic PLC
9.8 Olympus Corporation
9.9 Smith & Nephew
9.10 St. Jude Medical, Inc.
9.11 List Not Exhaustive
10. Future of the Market